Published in Transplant Proc on February 01, 1993
A prospective randomized trial of FK506-based immunosuppression after renal transplantation. Transplantation (1995) 2.09
A prospective, randomized trial of FK-506 in renal transplantation--a comparison between double- and triple-drug therapy. Clin Transplant (1994) 1.15
A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients. Transplant Proc (1995) 1.13
FK506 in pediatric kidney transplantation--primary and rescue experience. Pediatr Nephrol (1995) 1.11
The status of online Mendelian inheritance in man (OMIM) medio 1994. Nucleic Acids Res (1994) 8.00
Case-finding instruments for depression in primary care settings. Ann Intern Med (1995) 6.93
STUDIES ON THE MOLECULAR WEIGHT OF DIPHTHERIA TOXIN, ANTITOXIN, AND THEIR REACTION PRODUCTS. J Exp Med (1940) 4.51
The kinetics of reversible tight-binding inhibition. Methods Enzymol (1979) 4.13
Treatment of dysthymia and minor depression in primary care: a randomized trial in patients aged 18 to 59 years. J Fam Pract (2001) 3.21
Knowledge and attitudes about depression among non-generalists and generalists. J Fam Pract (1997) 2.51
Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA. Am J Transplant (2013) 2.45
Regulation of intercellular adhesion molecule-1 (CD54) gene expression. J Leukoc Biol (1999) 2.33
Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis. The CAFFS Trial: a randomized controlled trial. JAMA (2001) 2.29
Improving primary care for depression in late life: the design of a multicenter randomized trial. Med Care (2001) 2.27
Spore Formation among the Anaerobic Bacteria: I. The Formation of Spores by Clostridium sporogenes in Nutrient Agar Media. J Bacteriol (1941) 2.16
Splanchnic transplantation. An approach to the infant dependent on parenteral nutrition who develops irreversible liver disease. JAMA (1989) 2.10
IFN-gamma and IL-2 are protective in the skin but pathologic in the corneas of HSV-1-infected mice. J Immunol (1992) 1.90
A practical guide for the diagnosis and treatment of acute sinusitis. CMAJ (1997) 1.78
Behavioral responses to food volatiles by two species of stored-product coleoptera,Sitophilus oryzae (curculionidae) andTribolium castaneum (tenebrionidae). J Chem Ecol (1993) 1.73
Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitors. Am J Transplant (2014) 1.70
A simple modification in operative technique can reduce the incidence of nonanastomotic biliary strictures after orthotopic liver transplantation. Hepatology (1995) 1.59
Follow-up of patients with unexplained syncope and inducible ventricular tachyarrhythmias: analysis of the AVID registry and an AVID substudy. Antiarrhythmics Versus Implantable Defibrillators. J Cardiovasc Electrophysiol (2001) 1.55
The T cell repertoire for recognition of a phylogenetically distant protein antigen. Peptide specificity and MHC restriction of staphylococcal nuclease-specific T cell clones. J Exp Med (1986) 1.55
Purification and properties of gentamicin acetyltransferase I. Biochemistry (1976) 1.54
Increased competition may promote species coexistence. Proc Natl Acad Sci U S A (2002) 1.51
Efficacy of newer medications for treating depression in primary care patients. Am J Med (2000) 1.49
Methotrexate, a high-affinity pseudosubstrate of dihydrofolate reductase. Biochemistry (1979) 1.42
Competing demands: Does care for depression fit in primary care? J Gen Intern Med (1998) 1.41
Standardized comparison of performance indicators in trauma: a new approach to case-mix variation. J Trauma (1995) 1.40
Targeting depression interviewing: an exercise in diagnostic reasoning. J Gen Intern Med (1998) 1.38
INVASIVENESS OF SKIN INFECTIONS CAUSED BY PATHOGENIC FUNGI AND SUBSURFACE MYCELIUM. Science (1936) 1.37
Grading quality of evidence and strength of recommendations in clinical practice guidelines part 3 of 3. The GRADE approach to developing recommendations. Allergy (2011) 1.29
Mercuric reductase from R-plasmid NR1: characterization and mechanistic study. Biochemistry (1983) 1.25
Activation of B cells by autoreactive T cells: cloned autoreactive T cells activate B cells by two distinct pathways. J Immunol (1984) 1.24
Polyomavirus-associated nephropathy: update on antiviral strategies. Transpl Infect Dis (2006) 1.23
Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide. Intervirology (1999) 1.23
Performance of case-finding tools for depression in the nursing home: influence of clinical and functional characteristics and selection of optimal threshold scores. J Am Geriatr Soc (1994) 1.22
A mature T lymphocyte subpopulation marker closely linked to the Ig-1 allotype Ch locus. Eur J Immunol (1979) 1.21
An evaluation of leflunomide in the canine renal transplantation model. Transplantation (1994) 1.17
Placenta accreta: prospective sonographic diagnosis in patients with placenta previa and prior cesarean section. J Ultrasound Med (1992) 1.17
Cloning of the Escherichia coli K-12 dihydrofolate reductase gene following mu-mediated transposition. Gene (1980) 1.16
The immunosuppressive metabolite of leflunomide, A77 1726, affects murine T cells through two biochemical mechanisms. J Immunol (1997) 1.16
Inhibition of protein tyrosine phosphorylation in T cells by a novel immunosuppressive agent, leflunomide. J Biol Chem (1995) 1.15
Renal colic. Utility of the plain abdominal roentgenogram. Arch Intern Med (1991) 1.15
Protective effect of ischemic preconditioning on liver preservation-reperfusion injury in rats. Transplantation (1998) 1.14
Inhibition of the epidermal growth factor receptor tyrosine kinase activity by leflunomide. FEBS Lett (1993) 1.13
Isolation and characterization of a cell surface albumin-binding protein from vascular endothelial cells. Proc Natl Acad Sci U S A (1996) 1.13
An extensive exploration of the rat brain for sites mediating prostaglandin-induced hyperthermia. Brain Res (1977) 1.11
Inhibition of JAK3 and STAT6 tyrosine phosphorylation by the immunosuppressive drug leflunomide leads to a block in IgG1 production. J Immunol (1998) 1.10
"Endometrial" adenocarcinoma of the prostate: a distinctive tumor of probable prostatic duct origin. Cancer (1976) 1.09
Long-term effects of advice to consume a high-protein, low-fat diet, rather than a conventional weight-loss diet, in obese adults with type 2 diabetes: one-year follow-up of a randomised trial. Diabetologia (2004) 1.09
Leflunomide controls rejection in hamster to rat cardiac xenografts. Transplantation (1994) 1.09
Interleukin-10 inhibits interferon-gamma-induced intercellular adhesion molecule-1 gene transcription in human monocytes. Blood (1997) 1.08
Critical roles of glycosaminoglycan side chains of cartilage proteoglycan (aggrecan) in antigen recognition and presentation. J Immunol (1998) 1.08
Two activities of the immunosuppressive metabolite of leflunomide, A77 1726. Inhibition of pyrimidine nucleotide synthesis and protein tyrosine phosphorylation. Biochem Pharmacol (1996) 1.08
Impact of subclinical inflammation on the development of interstitial fibrosis and tubular atrophy in kidney transplant recipients. Am J Transplant (2010) 1.07
Acute interstitial nephritis. JAMA (1977) 1.07
Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide. Transplantation (1999) 1.06
Prediction of abstinence from ethanol in alcoholic recipients following liver transplantation. Hepatology (1997) 1.06
Substrate specificity and structure-activity relationships of gentamicin acetyltransferase I. The dependence of antibiotic resistance upon substrate Vmax/Km values. J Biol Chem (1978) 1.05
Complex pattern of Th1 and Th2 activation with a preferential increase of autoreactive Th1 cells in BALB/c mice with proteoglycan (aggrecan)-induced arthritis. Clin Exp Immunol (2000) 1.05
Retracted Peritransplant tolerance induction in macaques: early events reflecting the unique synergy between immunotoxin and deoxyspergualin. Transplantation (1999) 1.05
A survey of Massachusetts physicians' smoking intervention practices. Am J Prev Med (1988) 1.04
Basal and stimulated secretion of cytokines by peritoneal macrophages in women with endometriosis. Fertil Steril (1996) 1.04
Kinetic mechanisms of gentamicin acetyltransferase I. Antibiotic-dependent shift from rapid to nonrapid equilibrium random mechanisms. J Biol Chem (1978) 1.04
The preparation and properties of an antiserum for the radioimmunoassay of serum conjugated cholic acid. Clin Chim Acta (1974) 1.04
Synthesis of a tight-binding, multisubstrate analog inhibitor of gentamicin acetyltransferase I. J Antibiot (Tokyo) (1979) 1.04
Biopsy-directed immunosuppression following hepatic transplantation in man. Transplantation (1985) 1.04
Systematic review: is ingestion of paracetamol or non-steroidal anti-inflammatory drugs associated with exacerbations of inflammatory bowel disease? Aliment Pharmacol Ther (2004) 1.03
Interleukin-10 enhances tumor necrosis factor-alpha activation of HIV-1 transcription in latently infected T cells. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.02
Regulation of B cell function by the immunosuppressive agent leflunomide. Transplantation (1996) 1.02
Variations in susceptibility to proteoglycan-induced arthritis and spondylitis among C3H substrains of mice: evidence of genetically acquired resistance to autoimmune disease. Arthritis Rheum (2001) 1.02
Sequences outside a minimal immunodominant site exert negative effects on recognition by staphylococcal nuclease-specific T cell clones. J Immunol (1989) 1.02
Plasma insulin and growth hormone levels in untreated diabetic children. Arch Dis Child (1970) 1.02
High-fat feeding redirects cytokine responses and decreases allergic airway eosinophilia. Clin Exp Allergy (2009) 1.01
Transcriptional regulation of Fas gene expression by GA-binding protein and AP-1 in T cell antigen receptor.CD3 complex-stimulated T cells. J Biol Chem (1999) 1.00
In vivo activity of leflunomide: pharmacokinetic analyses and mechanism of immunosuppression. Transplantation (1999) 0.99
Evaluation of environmental distribution and fate of hexachlorocyclopentadiene, chlordene, heptachlor, and heptachlor expoxide in a laboratory model ecosystem. J Agric Food Chem (1975) 0.99
Urrets-Zavalia syndrome as a complication of argon laser peripheral iridoplasty. Br J Ophthalmol (2006) 0.98
Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection. Bone Marrow Transplant (2004) 0.98
The Isolation of Proplastids from Roots of Vicia faba. Plant Physiol (1972) 0.97
A genome scan using a novel genetic cross identifies new susceptibility loci and traits in a mouse model of rheumatoid arthritis. J Immunol (2000) 0.97
General internists influence students to choose primary care careers: the power of role modeling. Am J Med (1996) 0.97
Heritability of the maternal meiotic drive system linked to Om and high-resolution mapping of the Responder locus in mouse. Genetics (2000) 0.96
Carcinoid tumour of the terminal ileum simulating Crohn disease. Scand J Gastroenterol (2003) 0.96
The inhibition of dihydrofolate reductase by folate analogues: structural requirements for slow- and tight-binding inhibition. Biochem Pharmacol (1980) 0.96
Self-association of muramidase (lysozyme) in solution at 25 degrees, pH 7.0, and I = 0.20. Biochemistry (1970) 0.96
Two Y-chromosome-specific restriction fragment length polymorphisms (DYS11 and DYZ8) in Italian and Greek migrants to Australia. Hum Biol (1993) 0.95
Inhibition of herpes simplex virus type 1 by the experimental immunosuppressive agent leflunomide. Transplantation (2001) 0.95
In vivo mechanism by which leflunomide controls lymphoproliferative and autoimmune disease in MRL/MpJ-lpr/lpr mice. J Immunol (1997) 0.95
Near-GeV acceleration of electrons by a nonlinear plasma wave driven by a self-guided laser pulse. Phys Rev Lett (2009) 0.95